June 5, 2019 Clinical Research/Diagn. M&A, Partnerships

QIAGEN and DiaSorin collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease

Germantown, Maryland; Hilden, Germany and Saluggia, Italy, June 5, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced the expansion of their QuantiFERON collaboration to develop an ultra-sensitive diagnostic test for Lyme disease, which is expected to address a significant unmet medical need. The companies plan multi-site clinical... Read more

June 4, 2019 Clinical Research/Diagn. M&A, Partnerships

Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery

— Contributing to both the Cancer and Inflammation and Immunity Steering Committees —SAN FRANCISCO, June. 4, 2019 (BUSINESS WIRE) – Cofactor Genomics, pioneers in the field of Predictive Immune Modeling, announced today that they have become a member of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium with the goal of advancing... Read more

June 4, 2019 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne to Acquire B-MoGen Biotechnologies Inc.

JUNE 04, 2019 MINNEAPOLIS, June 4, 2019 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has been completed and is being financed through available cash on hand. “We are very pleased to include the B-MoGen technology in Bio-Techne’s expanding portfolio... Read more

June 4, 2019 Clinical Research/Diagn. Lab Top-10 Life Science Tools Product Launch

Illumina Introduces Expanded Version of VeriSeq™ NIPT Solution, Offering More Comprehensive Detection of Rare Chromosomal Conditions

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the launch of VeriSeq™ NIPT Solution v2, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT). The automated comprehensive solution allows laboratories to screen for a broader range of chromosomal and sub-chromosomal conditions associated with birth defects and adverse pregnancy outcomes than the standard NIPT... Read more

June 4, 2019 Clinical Research/Diagn. Lab Top-10 Product Launch

New Instrument for Automated Antimicrobial Susceptibility Testing Provides Gold Standard-Level Minimum Inhibitory Concentration (MIC) Accuracy1

New Instrument for Automated Antimicrobial Susceptibility Testing Provides Gold Standard-Level Minimum Inhibitory Concentration (MIC) Accuracy1 Instrument utilizes gold standard broth microdilution method to guide more targeted patient therapy and optimize patient outcomes BASINGSTOKE, England. (June 4, 2019) – A new benchtop automated reading and incubation system is now available in Europe for antimicrobial susceptibility testing... Read more

June 4, 2019 Clinical Research/Diagn. Product Launch

New Report Sheds Light on Health Care's 'Hidden' Epidemic – Hospital Drug Diversion – and its Role in the Opioid Crisis

FRANKLIN LAKES, N.J., June 4, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released a new report based on an independent national survey that examines drug diversion in U.S. hospitals, an underreported contributor to the opioid epidemic. Hospital drug diversion, when a health care worker “diverts” opiates... Read more

June 3, 2019 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal

Thermo Fisher Scientific's Oncomine Dx Target Test Receives Reimbursement Coverage in Japan

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives Reimbursement Coverage in Japan CARLSBAD, Calif., June 3, 2019 /PRNewswire/ — Thermo Fisher Scientific today announced that its Oncomine Dx Target Test CDx System has received reimbursement coverage from Japan’s Ministry of Health, Labour and Welfare and is now commercially available in that country. The next-generation sequencing (NGS)-based... Read more

June 3, 2019 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Announces Collaboration to Revolutionize Profiling of Large Plasma Sample Cohorts in Protein-based Clinical Research Studies

Thermo Fisher Scientific Announces Collaboration to Revolutionize Profiling of Large Plasma Sample Cohorts in Protein-based Clinical Research Studies ATLANTA, June 3, 2019 /PRNewswire/ — ASMS 2019 – Thermo Fisher Scientific, the world leader in serving science, and Evosep, a leading provider of sample preparation technologies for protein-based clinical research, have entered into a collaboration to develop... Read more

June 3, 2019 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships Mass Spectrometry

Thermo Fisher Scientific Renews Collaboration to Advance Plasma Quantitation Methods in Proteomics

Thermo Fisher Scientific Renews Collaboration to Advance Plasma Quantitation Methods in Proteomics Thermo Fisher and Biognosys to develop industry-leading mass spectrometry-based workflows for the efficient analysis of proteins in complex biological matrices ATLANTA, June 3, 2019 /PRNewswire/ — ASMS 2019 — Thermo Fisher Scientific, the world leader in serving science, and Biognosys, a leading developer of next-generation... Read more

June 3, 2019 Clinical Research/Diagn. PR/Corporate

Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 03 June 2019 Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting Roche data from 17 breast cancer abstracts presented at this year’s meeting An overall survival improvement was observed with Tecentriq and nab-paclitaxel in PD-L1-positive metastatic triple-negative breast cancer at the second... Read more